Company Profile

Tioga Research Inc
Profile last edited on: 1/4/2018      CAGE: 7F0W3      UEI: RKMNBDNECEV3

Business Identifier: Skin-applied formulations: topical & transdermal drugs, and cosmetic & beauty care products. We have particular strengths in formulation innovation and skin permeation screening.
Year Founded
2011
First Award
2017
Latest Award
2017
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

6330 Nancy Ridge Drive Suite 102
San Diego, CA 92121
   (858) 202-1569
   N/A
   www.tiogaresearch.com
Location: Single
Congr. District: 51
County: San Diego

Public Profile

Tioga Research, Inc. is strucrured around research and development of topical drug products, transdermal drug products, cosmetics, personal care products, and medical devices. The company provides skin applied products in various formulations, such as ointments, lotions, creams, solutions, gels, and foams. With expertise n formulation innovation and skin permeation screening, the firm offers CRO services in the areas of concept assessment, target product profile, preformulation and analytical, formulation innovation, skin permeation and delivery measurements, high thorough put experimentation, formulation optimization. The company also provides services in high throughput experimentation technologies for discovery and screening, R&D of generic drug products, and screening delivery of cosmeceuticals. In addition, Tioga also offer collaborative services: skin safety studies, preclinical proof of concept, active pharmaceutical ingredient and excipient sourcing, scale up and good manufacturing practices manufacturing, and investigational new drug application compilation and submission.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2017 1 NIH $256,191
Project Title: Reducing Dependency: Transdermal Patch to Deliver a Novel Potent Analgesic

Key People / Management

  John M Newsam -- CEO

  Judit Bartalis -- Manager Analytical Chemistry

  Meng Gao -- Operations Coordinator

  Edward Kisak -- CSO and Co-Founder

  David Riccardo -- Business Development Associate

Company News

There are no news available.